Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib

doi:10.3748/wjg.v27.i47.8166

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 47

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5260)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-8) series.

Item

Count

PDF

356

WORD

137

HTML

3229

Tables (1-8)

328

Sum=4050

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

420

Download

790

Sum=1210

Dec 21, 2021 (publication date) through Feb 14, 2025

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Dec 21, 2021; 27(47): 8166-8181
Published online Dec 21, 2021. doi: 10.3748/wjg.v27.i47.8166

Table 5 First pattern of intrahepatic progression in cases with intrahepatic progression

	All procedures (n = 100)	*TARE_alone* (n = 34)	*TARE_sorafenib* (n = 49)	*TARE_no_sorafenib* (n = 17)
Progression in treated area	75 (75)	23 (67.6)	40 (81.6)	12 (70.6)
New HCC	34 (34)	12 (35.3)	19 (38.8)	3 (17.6)
Recurrence/increased enhancement of previously treated HCC	20 (20)	5 (14.7)	9 (26.5)	6 (35.3)
With new MVI	8 (8)	2 (5.9)	6 (12.2)	0
With progressive MVI	3 (3)	0	3 (6.1)	0
With mixed patterns¹	10 (10)	4 (11.8)	3 (6.1)	3 (17.6)
Progression in untreated area	25 (25)	11 (32.4)	9 (18.4)	5 (29.4)

¹New HCC with one or more other patterns (n = 11) and new MVI with increased enhancement of previously treated HCC (n = 1). Values represent number of procedures (%). TARE: Transarterial radioembolization; HCC: Hepatocellular carcinoma; MVI: Macrovascular invasion.

Citation: Teyateeti A, Mahvash A, Long J, Abdelsalam M, Avritscher R, Kaseb A, Odisio B, Ravizzini G, Surasi D, Teyateeti A, Macapinlac H, Kappadath SC. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib. World J Gastroenterol 2021; 27(47): 8166-8181
URL: https://www.wjgnet.com/1007-9327/full/v27/i47/8166.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i47.8166